In a recent review, what was the incidence of Torsades des Pointes (TdP) in patients receiving droperidol?
Cole JB et al. performed a retrospective, observational cohort study from 1997-2001 in patients receiving parenteral droperidol for any indication. They found the incidence of TdP in emergency department patients receiving droperidol to be 1/16,546 or 0.006%.
Cole JB et al. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department. West J Emerg Med 2020; 21(4). doi: 10.5811/westjem.2020.4.47036